首页 | 本学科首页   官方微博 | 高级检索  
检索        

银杏叶提取物、卡托普利、缬沙坦单用及合用对高糖诱导的大鼠肾小球系膜细胞增殖肥大的影响
引用本文:翟云鹏,庞训雷,程乾,刘丽华,金幼红,鲁茜,印晓星.银杏叶提取物、卡托普利、缬沙坦单用及合用对高糖诱导的大鼠肾小球系膜细胞增殖肥大的影响[J].徐州医学院学报,2010,30(6):355-358.
作者姓名:翟云鹏  庞训雷  程乾  刘丽华  金幼红  鲁茜  印晓星
作者单位:徐州医学院药学院,江苏徐州,221004
基金项目:国家自然科学基金,江苏省高校自然科学研究计划项目,2007年江苏省大学生研究创新计划项目 
摘    要:目的研究卡托普利、缬沙坦及中药银杏叶提取物(GBE)对高糖培养的大鼠肾小球系膜细胞增殖肥大的影响,探讨三者单用及合用时的异同。方法体外培养大鼠肾小球系膜细胞(MC),分为正常(NS)组、甘露醇(MA)组、高糖(HG)组、溶媒(DMSO)组、GBE组、卡托普利(Cap)组、缬沙坦(Val)组以及GBE和卡托普利联合用药(GC)组、GBE和缬沙坦联合用药(GV)组。流式细胞仪测定细胞周期,MTT法检测细胞增殖变化情况。结果对高糖引起的细胞肥大,GBE单用、GBE联合Cap、GBE联合Val均可有效逆转,而Cap和Val单用时无此作用;对高糖诱导的细胞增殖,Cap、Val单用以及GBE联合Cap、GBE联合Val均可使其逆转,但GBE对其无明显影响。结论银杏叶提取物和卡托普利、缬沙坦联合应用时对大鼠MC的细胞保护作用更优。

关 键 词:糖尿病肾病  肾小球系膜细胞  细胞肥大  细胞增殖  银杏叶提取物  卡托普利  缬沙坦

Effects of monotherapy and combination therapy of Ginkgo biloba extract,captopril, valsartan on high glucose-induced proliferation and hypertrophy of rat mesangial cells
ZHAI Yunpeng,PANG Xunlei,CHENG Qian,LIU Lihua,JIN Youhong,LU Qian,YIN Xiaoxing.Effects of monotherapy and combination therapy of Ginkgo biloba extract,captopril, valsartan on high glucose-induced proliferation and hypertrophy of rat mesangial cells[J].Acta Academiae Medicinae Xuzhou,2010,30(6):355-358.
Authors:ZHAI Yunpeng  PANG Xunlei  CHENG Qian  LIU Lihua  JIN Youhong  LU Qian  YIN Xiaoxing
Institution:ZHAI Yunpeng,PANG Xunlei,CHENG Qian,LIU Lihua,JIN Youhong,LU Qian,YIN Xiaoxing(Faculty of Pharmacy,Xuzhou Medical College,Xuzhou,Jiangsu 221004,China)
Abstract:Objective To investigate the effect of captopril(CAP),valsartan(VAL) and Chinese crude drug Ginkgo biloba extract(GBE) on rat glomerular mesangial cells(MC) cultured in high glucose and to explore the differences between monotherapy and combination therapy of the drugs so as to provide rationale for captopril or valsartan combination therapy.Methods The rat MC line HBZY-1 was cultured in vitro in DMEM media.The cultured cells were divided into normal standard group(NS group,final concentration of 5.56 mmol·L-1 glucose),mannitol group(MA group,5.56 mmol·L-1 glucose + 24.44 mmol·L-1 mannitol),high glucose group(HG group,final concentration of 30 mmol·L-1 glucose),solvent control group(DMSO group,30 mmol·L-1 glucose + 0.1% DMSO),Ginkgo biloba extract group(GBE group,30 mmol·L-1 glucose + 0.1 % DMSO+20 g·L-1 GBE),captopril group(Cap group,30 mmol·L-1 glucose + 0.1 % DMSO+1 μmol·L-1 captopril),valsartan group(Val group,30 mmol·L-1 glucose + 0.1 % DMSO + 10 μmol·L-1 valsartan),captopril-GBE combination therapy group(GC group,30 mmol·L-1 glucose + 0.1 % DMSO + 20 g·L-1 GBE + 1 μmol·L-1 captopril),and valsartan-GBE combination therapy group(GV group,30 mmol·L-1 glucose + 0.1 % DMSO + 20 g·L-1 GBE + 10 μmol·L-1 valsartan).After corresponding treatment,the cell cycles were determined by flow cytometry,and cell proliferation was evaluated by MTT.Results GBE and its combination with either captopril or valsartan could reverse cell hypertrophy induced by high glucose,while neither captopril nor valsartan monotherapy could achieve that effect.Likewise,GBE and its combination with either captopril or valsartan could reverse cell proliferation induced by high glucose,while GBE had no significant effect.Conclusions GBE in combination with either captopril or valsartan had better cytoprotective effect on rat MC.
Keywords:diabetic nephropathy  glomerular mesangial cell  cell hypertrophy  cell proliferation  Ginkgo biloba extract  captopril  valsartan  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号